Related Experiment Video
Updated: Apr 22, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial
Tze-Fan Chao1, Chia-Jen Liu2, Kang-Ling Wang1
1Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.
Insights
The CHA2DS2-VASc score is superior to the ATRIA score for predicting ischemic stroke in atrial fibrillation patients. ATRIA misclassifies many patients as low-risk, while CHA2DS2-VASc accurately identifies truly low-risk individuals.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Atrial fibrillation (AF) necessitates risk stratification for ischemic stroke.
- The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score is a proposed system for AF risk assessment.
- The ability of the ATRIA score to identify low-risk AF patients for stroke remains uncertain.
Purpose of the Study:
- To compare the predictive performance of the ATRIA score against the CHA2DS2-VASc score for ischemic stroke in AF patients.
- To evaluate the accuracy of both scoring systems in identifying low-risk individuals.
Main Methods:
- Utilized the National Health Insurance research database in Taiwan.
- Included 186,570 AF patients not receiving antithrombotic therapy.
- Assessed ischemic stroke as the primary clinical endpoint over a mean follow-up of 3.4 years.
Main Results:
- CHA2DS2-VASc demonstrated superior predictive accuracy over ATRIA (c-index 0.698 vs. 0.627, p < 0.0001).
- CHA2DS2-VASc significantly improved risk reclassification by 11.7% compared to ATRIA (p < 0.0001).
- Among patients with ATRIA score 0-5, CHA2DS2-VASc identified a wide range of stroke risks, with significantly better discrimination (c-index 0.629 vs. 0.593, p < 0.0001).
Conclusions:
- The ATRIA score inadequately identifies low-risk AF patients, with annual stroke rates up to 2.95% at 1 year.
- AF patients with a CHA2DS2-VASc score of 0 represent a truly low-risk group, with an approximate 1% annual stroke rate.
- CHA2DS2-VASc is a more reliable tool for stroke risk stratification in AF patients compared to ATRIA.
Background:
A new scoring system, the anticoagulation and risk factors in atrial fibrillation (ATRIA) score, was proposed for risk stratification in patients with atrial fibrillation (AF). Whether the ATRIA scheme can adequately identify patients who are at low risk of ischemic stroke remains unknown.
Objectives:
The goal of the present study was to compare the performance of ATRIA to that of CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75, diabetes mellitus, prior stroke or transient ischemic attack, vascular disease, age 65 to 74, female) scores for stroke prediction.
Methods:
This study used the National Health Insurance research database in Taiwan. A total of 186,570 AF patients without antithrombotic therapy were selected as the study cohort. The clinical endpoint was the occurrence of ischemic stroke.
Results:
During the follow-up of 3.4 ± 3.7 years, 23,723 patients (12.7%) experienced ischemic stroke. The CHA2DS2-VASc score performed better than ATRIA score in predicting ischemic stroke as assessed by c-indexes (0.698 vs. 0.627, respectively; p < 0.0001). The CHA2DS2-VASc score also improved the net reclassification index by 11.7% compared with ATRIA score (p < 0.0001). Among 73,242 patients categorized as low-risk on the basis of an ATRIA score of 0 to 5, the CHA2DS2-VASc scores ranged from 0 to 7, and annual stroke rates ranged from 1.06% to 13.33% at 1-year follow-up and from 1.15% to 8.00% at 15-year follow-up. The c-index of CHA2DS2-VASc score (0.629) was significantly higher than that of the ATRIA score (0.593) in this "low-risk" category (p < 0.0001).
Conclusions:
Patients categorized as low-risk by use of the ATRIA score were not necessarily low-risk, and the annual stroke rates can be as high as 2.95% at 1-year follow-up and 2.84% at 15-year follow-up. In contrast, patients with a CHA2DS2-VASc score of 0 had a truly low risk of ischemic stroke, with an annual stroke rate of approximately 1%.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(two-step method)

